Cosmos Pharmaceutical Corp operates in the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cosmos Pharmaceutical Corp with three other
companies in this sector in Japan:
Sugi Holdings Company Limited
sales of 414.89 billion Japanese Yen [US$3.72 billion]
of which 100%
was Drug Compounding Business),
Cocokara Fine Incorporated
(373.28 billion Japanese Yen [US$3.35 billion]
of which 99%
was Drug & Dispense), and
Sundrug Co Ltd
(503.77 billion Japanese Yen [US$4.52 billion]
of which 67%
was Drugstore Business).
Cosmos Pharmaceutical Corp reported sales of ¥447.27 billion (US$4.01 billion)
May of 2016.
increase of 9.5%
versus 2015, when the company's sales were ¥408.47 billion.
Sales at Cosmos Pharmaceutical Corp have increased during each of the previous five years
(and since 2011, sales have increased a total of 89%).